As shown in Figures 6B–D, there were significant differences in the composite indexes tumor-infiltrating CD11b/CD3 and CD11b/(CD3+CD19) ratios between pNLR-high and pNLR-low patients (Mann–Whitney U test, p = 0.007, 0.011, respectively). This evidence concerns the gene CD19 and neoplasm.